RNA-seq reveals transcriptomic differences in circadian-related genes of the choroid plexus in a preclinical chronic migraine model.

BackgroundMigraine patients show choroid plexus (CP) changes, impairing the blood-CSF barrier. The CP regulates circadian rhythms, but links between CP circadian genes and migraine are unexplored. ObjectiveThis study examined CP circadian gene transcriptome changes in a chronic migraine rat model versus controls to identify migraine-related pathways. DesignChronic migraine model: Sprague Dawley rats (3 females, 3 males) received nitroglycerine (NTG) every other day for 9 days; controls (3 females, 3 males) got saline. CP from the 4th ventricle was collected 2 hours post-final injection for RNAseq. MethodsMigraine Behavior: Von Frey hair tests on days 1, 5, and 9, pre- and 2 hours post-NTG/saline injection, assessed basal and NTG-induced pain thresholds. RNAseq & Analysis: Differentially expressed genes (p 1) were identified. GO, KEGG, and Reactome enrichment analyses evaluated circadian gene expression changes. ResultsO_LINTG group showed reduced basal and NTG-induced pain thresholds on days 1, 5, and 9. C_LIO_LIFemales had more upregulated genes (MT2A, SLC7A11), males upregulated ZBTB16, S100A8. SLC7A11, SCG2, GRIA1 showed inverse regulation (up in females, down in males). C_LIO_LICircadian gene expression altered: 10 genes upregulated (e.g., SERPINE1, MAPK9, ATF4), 13 downregulated (e.g., PER2, DBP, EZH2). Sex-specific differences: females (FBXL12, GPR157), males (NKX2-1, ATF4, CLOCK). C_LIO_LIGO/KEGG analyses revealed significant enrichment of circadian rhythm-related pathways, insulin resistance, and inflammatory response processes, with sex-specific differences: females showed HIF-1 signaling and hemoglobin-related pathways, while males exhibited arachidonic acid and leukotriene production. C_LI ConclusionCP transcriptomics in the rat migraine model revealed sex-specific gene regulation, with females upregulating antioxidant genes (MT2A, SLC7A11) and males upregulating inflammatory factors (ZBTB16, S100A8), alongside circadian disruption (e.g., SERPINE1 upregulated, PER2 downregulated). Pathway analyses indicate enriched circadian rhythms, HIF-1 signaling (females), inflammatory processes (males), lipid metabolism (PPAR), and heme signaling, highlighting sex-specific and circadian targets for migraine therapy.